Download
https://www.ndtvprofit.com/markets/aurobindo-pharma-shares-drop-8-after-us-fda-action-on-srikakulam-plant?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Aurobindo says existing business at the plant will not be impacted and it’s committed toward fixing this issue at the earliest.
Share